The Bio/Pharma Beat

    View Author August 2019

    We would like to share with you the Bio/Pharma Beat, our monthly newsletter reporting on the patent law developments you should know in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from July 2019, including:

    • A sharply divided Federal Circuit denies en banc rehearing on the controlling nature of Supreme Court section 101 case law in the diagnostics realm
    • The DC district court vacates and remands an FDA exclusivity determination
    • HHS announcing a plan to lay the foundation for importation of drugs from Canada and other countries